Inspira Technologies Oxy B.H.N Valuation

Is IINN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IINN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate IINN's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate IINN's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IINN?

Key metric: As IINN is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for IINN. This is calculated by dividing IINN's market cap by their current book value.
What is IINN's PB Ratio?
PB Ratio	4.5x
Book	US$5.74m
Market Cap	US$25.16m

IINN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	-1.6x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does IINN's PB Ratio compare to its peers?

The above table shows the PB ratio for IINN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	4.8x
STIM Neuronetics	3.1x	47.5%	US$29.4m
VASO Vaso	0.9x	n/a	US$22.7m
FEMY Femasys	4.1x	21.1%	US$25.2m
IRIX IRIDEX	11.2x	n/a	US$29.4m
IINN Inspira Technologies Oxy B.H.N	4.5x	n/a	US$25.2m

Price-To-Book vs Peers: IINN is good value based on its Price-To-Book Ratio (4.5x) compared to the peer average (4.8x).

Price to Book Ratio vs Industry

How does IINN's PB Ratio compare vs other companies in the US Medical Equipment Industry?

27 Companies	Price / Book	Estimated Growth	Market Cap
ADGM Adagio Medical Holdings	0.5x	n/a	US$37.79m
CODX Co-Diagnostics	0.5x	-8.3%	US$31.61m
RVP Retractable Technologies	0.2x	n/a	US$18.86m
MHUA Meihua International Medical Technologies	0.09x	n/a	US$15.40m

27 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: IINN is expensive based on its Price-To-Book Ratio (4.5x) compared to the US Medical Equipment industry average (2.6x).

Price to Book Ratio vs Fair Ratio

What is IINN's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IINN PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	4.5x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate IINN's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Lantheus Holdings

US$6.3b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.

LNTH

US$89.53

12.7%

29.8%

Elevance Health

US$94.5b

Operates as a health benefits company in the United States.

ELV

US$401.96

2.0%

-15.5%

Centene

US$31.0b

Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States.

CNC

US$60.00

3.8%

-17.8%